荷兰法院驳回股东调查请求，飞利浦赢得召回诉讼关键一仗
荷兰一家法院10月10日星期六驳回了飞利浦股东提出的调查要求，股东指控这家健康科技公司在睡眠呼吸暂停设备召回问题上披露误导、管理失当。
一大批股东此前要求法院展开调查，称飞利浦高管对导致大规模召回的问题反应太晚，且未充分告知投资者。2021年，飞利浦召回约1500万台睡眠呼吸暂停设备，因发现机器内泡沫可能释放有害物质并带来健康风险，公司股价一度蒸发约三分之二。
阿姆斯特丹上诉法院企业法庭在裁决中表示，没有迹象表明飞利浦在发出任何警告之前很久就已知晓问题，也没有理由认为高管应更早干预制造这些设备的Respironics子公司。
飞利浦否认股东指控并表示欢迎法院裁决。该召回已引发多国调查，包括法国检察官仍在调查的加重欺诈与未报告安全风险指控。
Philips Wins Dutch Court Battle With Shareholders Over Sleep Apnea Recall
A Dutch court on Saturday, October 10, dismissed demands by Philips shareholders for an investigation into allegations of misleading disclosures and management failures linked to the company's recall of sleep apnea devices.
A large group of shareholders had demanded a court inquiry, saying Philips executives responded too late to the problems that led to the massive recall and failed to adequately inform investors. Philips recalled around 15 million sleep apnea devices in 2021 after discovering foam in the machines could release harmful substances; its shares lost about two-thirds of their value.
The Enterprise Chamber of the Amsterdam Court of Appeal said it found no indication Philips had known about the problems long before issuing any warning, and no reason to assume executives should have intervened earlier at the Respironics subsidiary that made the devices.
Philips denied the shareholders' accusations and welcomed the decision. The recall has led to probes in multiple countries, including France, where prosecutors are still investigating aggravated fraud and failure-to-report charges.
图片来源：图：HeadPhilips.jpg，作者：No machine-readable author provided. Migdejong assumed (base，授权：Public domain，来源：Wikimedia Commons
